Low dose sirolimus for long COVID
Part of Infections, Lungs & breathing clinical trials.
This trial tests if a low dose of sirolimus, a medicine that calms the immune system, can help people with long COVID. If you have had long COVID symptoms for at least 6 months, like severe fatigue, brain fog, or chest pain, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a confirmed or suspected COVID-19 infection at least 6 months ago.
- A doctor has diagnosed you with long COVID.
- You have at least one ongoing symptom such as headache, memory problems, trouble sleeping, mood changes, chest pain, heart palpitations, shortness of breath, cough, muscle or joint pain, or stomach issues.
- You have at least moderate fatigue and moderate post-exertional malaise (feeling much worse after activity).
- You can travel to New York City (5 East 98th Street) for all study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.
This trial tests whether immune-modulating treatments can help people with long covid, especially those with ongoing heart, cough, or fatigue symptoms. It aims to see if calming the immune system reduces symptoms and improves daily life.
This trial tests a care program designed to help people who continue to have symptoms after recovering from COVID-19. It aims to prevent long-term health problems and improve well-being.
This trial tests a medicine called Sonlicromanol to see if it helps people with lingering symptoms after a mild case of COVID-19. It is for people who have post-exertional malaise (feeling very tired or worse after activity) and a moderate level of disability.
This study tests whether a lab-made antibody (sipavibart) can reduce Long COVID symptoms. It is for people who developed Long COVID after a confirmed COVID infection and still have moderate to severe fatigue and other ME/CFS-like symptoms.
This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.
Hear when a new Long Covid-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.